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modilution has been shown (15) . _ to underestimate cardiac 
output in patients with tricuspid regurgitation. Fick cardiac 
output for determination f forward stroke volume remains 
the reference standard inthis patient group. 
Many of the exercise hemodynamic and ventricular VOl- 
ume data and the derived total ejection fraction and for-ward 
fraction were obtained utilizing equilibrium gated radionu- 
elide ventriculography. Because this kind of information is
not so easily derived noninvasively, the validity of measur- 
ing absolute ventricular volumes by the count-based radio- 
nuclide method employed by Stevenson etal. (I) deserves 
comment. When such a nongeometric adionuclide imaging 
approach is utilized to determine ventricular volumes, the 
following pitfalls or problems are encountered: 
1. There is incomplete separation of the left ventricular 
chamber f om the atria and aorta even using “the best septal 
left anterior oblique projection.‘* asdescribed by the authors 
(I). 
2. Defining the borders (edge detection) of the left ven- 
tricular cavity by manually drawing a region of interest 
around the ventricle is somewhat subjective and associated 
with unavoidable interobserver variability. No highly repro- 
ducible automatic edge detection algorithm isavailable that 
can be applied accurately for this purpose. 
3. There may be an incorrect estimation of the back- 
ground activity that has to be subtracted. When background 
is oversubtracted because it is overestimated, theresult will 
be an underestimation of left ventricular volume. Scatter of 
radioactivity from the heart and adjacent tissues may con- 
tribute to this overestimation &background. 
4. There is significant ches,t wall attenuation f radiation 
emanating from the left ventricle, as well as self-attenuation 
within the left ventricular blood pool that has to be corrected 
when measuring absolute cardiac volumes (16). 
Attenuation correction f@Jr adionuclide termination f 
left ventricular volumes. Despite these multiple factors that 
potentially introduce rrors into the ventricular volume 
measurements, reported validation studies (17-19) demon- 
strate surprisingly good c,arrelation f radionuclide-derived 
stroke volumes with contrast ventriculographic and Fick- 
determined stroke volumes. A major advance in this area 
occurred when an appropriate attenuation correction tech- 
nique was introduced by Links et al. (20). Attenuation 
correction is accomplished successfully by counting a 
venous ample of known volume under the collimator of the 
gamma camera nd determining the depth of the center of 
the left ventricle. Left ventricular (LV) volume in milliliters 
is then calculated from the following equation: 
LV volume (ml) = 99mTc counts in LV-background x ,,_ud 
Blood sample counts/ml-background ’ ’
where ewud 
cm-‘, 
is the attenuation corrector factor; u is 0.15 
which is the linea: attenuation coefficient of water: 
and d is the depth of the center of the left ventricle. 
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Sengths oj’the present study regarding this radionuclide 
technique are that attenuation factors were measured for 
each patient in both supine and upright positions, distances 
were measured by three observers and averaged, and in 
these investigator hands there is an acceptable interobserver 
variability for measuring ventricular counts (6.5%) and de- 
termining attenuation factors (2.6%) that yields a total vol- 
ume estimate variability of 8.5%. Because ach patieilt 
served as his or her own control, even if some errors were 
systematically introduced inthe absolute volume determina- 
tions, the changes with exercise, with and without afterload 
reduction therapy, should be relatively accurate. Finally, in 
the present study the authors how that when radionuclide 
ventriculographic volume measurements are combined with 
simultaneously calculated thermodilution stroke volumes, 
dynamic hanges in mitral regurgitation with pharmacologic 
interventions can be assessed successfully during both rest 
and exercise. 
Conclusions. The hypothesis that secondary mitral regur- 
gitation in congestive heart failure may be a marker for a 
subgroup of patients most likely to benefit from unloading 
therapy is untested to date. It is hoped that future trials 
evaluating mortality and symptomatic benefit of load reduc- 
tion in congestive heart failure will examine this variable. 
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